Calmodulin-dependent cyclic nucleotide phosphodiesterase in human cerebral cortex and glioblastoma multiforme

Canadian Journal of Neurological Sciences

Volumn 23, Issue 4, 1996, Pages 245-250

  Lal, Sumeer ^a   Raju, Rajala V S ^b   Macaulay, Robert J B ^b   Sharma, Rajendra K ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CALMODULIN; CALMODULIN BINDING PROTEIN; POLYCLONAL ANTIBODY;

ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; BRAIN TISSUE; CROSS REACTION; IMMUNOBLOTTING; IMMUNOCHEMISTRY; MOLECULAR WEIGHT; PH; PRIMARY TUMOR; PROTEIN EXPRESSION; STEREOTACTIC BIOPSY; TEMPORAL LOBE; TEMPORAL LOBECTOMY;

EID: 0029802529     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100038178     Document Type: Article

References (47)

1. Hickie RA, Walker CM, Croll GA. Decreased cyclic adenosine 3′:5′-monophosphate levels in Morris hepatoma 5123 t.c.(h). Biochem Biophys Res Commun 1974; 59: 167-173.
2. Hickie RA, Jan SH, Datta A. Comparative adenylate cyclase activities in homogenate and plasma membrane fractions in Morris hepatoma 5123 t.c.(h). Cancer Res 1975; 35: 596-600.
3. m cyclic adenosine 3′:5′- monophosphate phosphodiesterases in Morris hepatoma 5123 t.c.(h). Cancer Res 1975; 35: 601-605.
4. Hickie RA. Regulation of cyclic AMP and cyclic GMP. In: Morris HP, Criss WE, eds. Morris Hepatomas: Mechanisms of Regulation. New York: Plenum Publishing Corp., 1978: 451-488.
5. Halfman DM, Kuo JF. A homogeneous cyclic CMP phosphodiesterase hydrolyzes both pyrimidine and purine cyclic 2′:3′- and 3′:5′-nucleotides. J Biol Chem 1982; 257: 1044-1047.
6. Whitfield JF. Calcium signals and cancer. Clin Rev Oncogenesis 1992; 3: 55-90.
7. Van C, Bentley JK, Sonnenburg W, et al. Differential expression of the 61 kDa and 63 kDa calmodulin-dependent phosphodiesterases in the mouse brain. J Neurosci 1994; 14: 973-984.
8. Epstein PM, Hachisu R. Cyclic neucleotide phosphodiesterase in normal and leukemic human lymphocytes and lymphoblasts. Adv Cyclic Nuc Prot Phosph 1984; 16: 303-324.
9. Onali P, Strada SJ, Chang L, et al. Purification and characterization of high-affinity cyclic adenosine 5′-monophophate phosphodiesterases from human actue myelogenous leukemic cells. Cancer Res 1985; 45: 1384-1391.
10. Aleksijec A, Lungnier C, Giron C. et al. Cyclic AMP and cyclic GMP phosphodiesterase activities in Hodgkin's disease lymphocytes. Int J Immunopharmacol 1987; 9: 525-531.
11. Wei J-W, Hickie RA. Decrease activities of cyclic cytidine3′:5′ monophosphate phosphodiesterase in Morris hepatomas having varying growth rates. Int J Biochem 1983; 15: 789-795.
12. Turnbull JL, Hickie RA. The isolation and characterization of cyclic nucleotide phosphodiesterase from Morris hepatoma 5123 t.c.(h) and rat liver. Int J Biochem 1984; 16: 19-29.
13. Kumar S, Becker G, Prasad KM. Cyclic adenosine 3′:5′-monophosphate phosphodiesterase activity in malignant and cyclic adenosine 3′:5′-monophosphate-induced "differentiated" neuroblastoma cells. Cancer Res 1975; 35: 82-87.
14. Singer AL, Sherwin RP, Dunn AS, et al. Cyclic nucleotide phosphodiesterase in neoplastic and non-neoplastic mammary tissues. Cancer Res 1976; 36: 60-66.
15. Kakiuchi S, Yamazaki R. Calcium-dependent phosphodiesterase activity and its activating factor (PAF) from brain studies on cyclic 3′: 5′-nucleotide phosphodiesterase. Biochem Biophys Res Commun 1970; 41: 1104-1110.
16. 2+. Proc Natl Acad Sci USA 1973; 70: 3526-3530.
17. Cheung WY. Cyclic 3′:5′-nucleotide phosphodiesterase. Determination of activator. Biochem Biophys Res Commun 1970; 38: 533-538.
18. Teo TS, Wang JH. Mechanisms of activation of cyclic adenosine 3′:5′ monophosphate phosphodiesterase from bovine heart by calcium ions. J Biol Chem 1973; 248: 5950-5955.
19. Sharma RK. Calmodulin-stimulated cyclic nucleotide phosphodiesterase isozymes. Mol Aspects Cell Reg 1988; 5: 265-295.
20. Wang JH, Sharma RK, Mooibroek MJ. Calmodulin stimulated cyclic nucleotide phosphodiesterase. Mol Pharm Cell Reg 1990; 2: 19-59.
21. 2+-calmodulin dependent cyclic nucleotide phosphodiesterase (PDEI) In: G Dent, R Klaus and C Schudt, eds. The Handbook of Immunopharmacology-Phosphodiesterase Inhibitors. London Academic Press, 1996: (in press).
22. Wells JM, Hardman JG. Cyclic nucleotide phosphodiesterases. Adv Cyclic Nucleotide Res 1977; 8: 119-143.
23. Hansen RS, Beavo JA. Purification of two calcium calmodulin-dependent forms of cyclic nucleotide phosphodiesterase by using conformation-specific monoclonal antibody chromatography. Proc Natl Acad Sci USA 1982; 79: 2788-2792.
24. Sharma RK. Phosphorylation and characterization of bovine heart calmodulin-dependent phosphodiesterase. Biochemistry 1991; 30: 5964-5968.
25. Sharma RK, Wang JH. Purification and characterization of bovine lung calmodulin-dependent cyclic nucleotide phosphodiesterase. J Biol Chem 1986; 261: 14160-14166.
26. Sharma RK, Adachi AM, Adachi K, et al. Demonstration of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme by monoclonal antibodies. J Biol Chem 1984; 259: 9248-9254.
27. Purvis K, Olsen A, Hansson V. Calmodulin-dependent cyclic nucleotide phosphodiesterase in the immature rat testis. J Biol Chem 1981; 256: 11434-11441.
28. Vandermeers A, Vandermeers-Piret MC, Rathe J, et al. Purification and kinetic properties of two soluble forms of calmodulin-dependent cyclic nucleotide phosphodiesterase from rat pancreas. Biochem J 1983; 211: 341-347.
29. Rossi P, Giorgi M, Geremia R, et al. Testis specific calmodulin-dependent phosphodiesterase. A distinct high affinity cAMP isozyme immunologically related to brain calmodulin-dependent cGMP phosphodiesterase. J Biol Chem 1983; 263: 15521-15527.
30. Sharma RK, Kalra J. Characterization of calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes. Biochem J 1994; 299: 97-100.
31. Sharma RK, Wang JH. Differential regulation of calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme by cyclic-AMP dependent protein kinase and calmodulin dependent phosphatase. Proc Natl Acad Sci USA 1985; 82: 2603-2607.
32. Florio VA, Sonnenburg WK, Johnson R, et al. Phosphorylation of the 61 kDa calmodulin-stimulated cyclic nucleotide phosphodiesterase at serine 120 reduces its affinity for calmodulin. Biochemistry 1994; 33: 8948-8954.
33. Sharma RK, Wang JH. Regulation of 63 kDa subunit containing isozyme of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase by a calmodulin-dependent protein kinase. J Biol Chem 1986; 261: 1322-1328.
34. 2+-independent activities and kinetic parameters. J Biol Chem 1987; 262: 8051-8055.
35. Zhang GY, Wang JH, Sharma RK. Purification and characterization of bovine brain calmodulin-dependent protein kinase II. The significance of autophosphorylation in the regulation of 63 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme. Mol Cell Biochem 1993; 22: 159-169.
36. Sharma RK, Wang JH. Isolation of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes. Methods Enzymol 1988; 159: 582-594.
37. Voller A, Bartlett A, Bidwell DE. Enzyme immune assay with special reference to ELISA technique. J Clin Pathol 1978; 31: 507-520.
38. 2+-dependent modulator protein. Adv Cyclic Nucleotide Res 1979; 10: 187-198.
39. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
40. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principles of protein-dye binding. Anal Biochem 1976; 72: 248-254.
41. Sharma RK. Purification and characterization of novel calmodulin-binding protein from cardiac muscle. J Biol Chem 1990; 265: 1152-1157.
42. Russell DS, Rubenstein LS. Pathology of Tumors of the Nervous System. Williams and Wilkins, 5th ed, 1990: 219-246.
43. Harsh GR, Wilson CB. Neuroepithelial Tumors of the Adult Brain, Youmans Neurological Surgery. New York W.B. Saunders, 1989; 5: 3040-3136.
44. Brostrom C, Wolf D. Calcium-dependent cyclic nucleotide phosphodiesterase from glial tumor cells. Arch Biochem Biophys 1974; 65: 715-727.
45. Stefanovich V, Ambrus J, Karakousis C, et al. Cyclic nucleotide phosphodiesterases in normal and malignant human tissue. J Medicine 1981; 12: 243-250.
46. Whitfield JF, Boynton AL, MacManus JP, et al. The regulation of cell proliferation by calcium and cyclic AMP. Mol Cell Biochem 1979; 27: 155-179.
47. Schuller H. The signal transduction model of carcinogenesis. Biochem Pharm 1991; 42: 1511-1523.